ShervinRabizadehMD

Pediatric Gastroenterology • Los Angeles, CA

Chair, Department of Pediatrics, Cedars-Sinai Medical Center

Join to view full profile

Dr. Rabizadeh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rabizadeh's full profile

Already have an account?

Office
8700 Beverly Blvd
Los Angeles, CA 90048
Phone+1 310-423-5000

Fax+1 310-423-0120

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Gastroenterology, 2004 - 2008
Johns Hopkins UniversityResidency, Pediatrics, 2001 - 2004
Tufts University School of MedicineClass of 2001

Certifications & Licensure

CA State Medical License 2008 - 2026
MD State Medical License 2004 - 2009
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Gastroenterology

Clinical Trials

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) Start of enrollment: 2022 Apr 30
Recruiting
Phase 3
Roles: Principal Investigator
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) Start of enrollment: 2022 Apr 18
Recruiting
Phase 3
Roles: Principal Investigator

Publications & Presentations

PubMed

6 citations
Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease.
Michelle Khrom, Millie Long, Shishir Dube, Lori Robbins, Gregory J Botwin
Gastroenterology. 2024-07-01
1 citations
Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel disease.
Severine Vermeire, Marla C Dubinsky, Shervin Rabizadeh, John C Panetta, Elisabeth A Spencer
Clinics and Research in Hepatology and Gastroenterology. 2024-06-01
Pre-operative visceral adipose tissue radiodensity is a potentially novel prognostic biomarker for early endoscopic post-operative recurrence in Crohn's disease.
Phillip Gu, Shishir Dube, Norman Gellada, So Yung Choi, Susan Win
World Journal of Gastrointestinal Surgery. 2024-03-27

Press Mentions

Cedars-Sinai Guerin Children's Opens to PatientsAugust 5th, 2022
A First Look at Cedars-Sinai Guerin Children’sJune 14th, 2022
Young Patients Seeing Inflammatory Bowel SpikeOctober 24th, 2018
Join now to see all

Grant Support

Role Of Innate Immunity And STAT3 Activation In Colitis Mouse ModelNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011
STAT3 Activation In Bacteria-Induced Murine TH17 Predominant Colonic InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases2008
STAT3 Activation In Bacteria-Induced Murine TH17 Predominant Colonic InflammationNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008